Cite
HARVARD Citation
Wang, X. et al. (n.d.). Derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates. Journal of clinical pharmacology. pp. 63-72. [Online].